Literature DB >> 12603287

Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale.

G P Anzola1, P Zavarize, E Morandi, L Rozzini, G Parrinello.   

Abstract

The importance of patent foramen ovale (PFO) in stroke of unknown cause remains disputed, as PFO may be present in up to 20% of normal people and in a high proportion of patients with non-vascular disorders. Recent evidence suggests that the amount of right-to-left shunt (RLS) may be the crucial factor for stroke occurrence and relapse. The aim of the study was to assess predictors of recurrence in PFO-related stroke patients with particular emphasis on amount of shunting. Patients less than 61 years old who had been admitted for a PFO-related stroke within the previous 5 years, were re-evaluated on a follow-up visit. The clinical syndrome, residual disability, vascular risk factors and number of relapses as the index event were assessed. RLS sizing was semi-quantitatively performed with saline-enhanced transcranial Doppler (TCD), by assuming a cut-off of more or less 10 bubbles recorded in the cerebral vessels as a criterion to discriminate large versus small shunt, respectively. Thereafter patients were prospectively followed-up for a median time of 23 months. Total follow-up was 61 months. Fifty-nine patients (M/F = 23/36, mean age 43 +/- 13) were studied. Overall there were 23 relapses in 13 patients. The amount of shunting was the only significant independent variable associated with relapse: at the end of the follow-up period the recurrence rate was 0.66 and 8.2% per patient per year in patients with small and large shunt, respectively. This difference was statistically significant (chi2 = 10.39, P = 0.0012; OR 17.05, 95% CI 2.10-755.22). In patients with PFO-related stroke, the amount of RLS as assessed with TCD is the only independent predictor of relapse. PFO sizing is mandatory in patients with PFO.

Entities:  

Mesh:

Year:  2003        PMID: 12603287     DOI: 10.1046/j.1468-1331.2003.00561.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  16 in total

Review 1.  Stroke in younger patients: the heart of the matter.

Authors:  P E Cotter; M Belham; P J Martin
Journal:  J Neurol       Date:  2010-07-11       Impact factor: 4.849

2.  Patent foramen ovale: the never-ending story.

Authors:  Gérald Devuyst; Julien Bogousslavsky
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

Review 3.  Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence.

Authors:  Georgios D Kitsios; Issa J Dahabreh; Abd Moain Abu Dabrh; David E Thaler; David M Kent
Journal:  Stroke       Date:  2011-12-15       Impact factor: 7.914

4.  Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO study.

Authors:  Domenico Consoli; Maurizio Paciaroni; Marco Aguggia; Maurizio Melis; Giovanni Malferrari; Simone Vidale; Paolo Cerrato; Simona Sacco; Carlo Gandolfo; Paolo Bovi; Carlo Serrati; Massimo Del Sette; Anna Cavallini; Marina Diomedi; Paolo Postorino; Stefano Ricci
Journal:  Neurol Sci       Date:  2014-01-01       Impact factor: 3.307

Review 5.  Rethinking trial strategies for stroke and patent foramen ovale.

Authors:  David E Thaler; David M Kent
Journal:  Curr Opin Neurol       Date:  2010-02       Impact factor: 5.710

Review 6.  The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease.

Authors:  Mingming Ning; Eng H Lo; Pei-Chen Ning; Su-Yu Xu; David McMullin; Zareh Demirjian; Ignacio Inglessis; G William Dec; Igor Palacios; Ferdinando S Buonanno
Journal:  Pharmacol Ther       Date:  2013-03-23       Impact factor: 12.310

7.  Prevention strategies for cardioembolic stroke: present and future perspectives.

Authors:  Giacomo Giacalone; Mohammed Abballa Abbas; Francesco Corea
Journal:  Open Neurol J       Date:  2010-06-15

8.  Decrease in shunt volume in patients with cryptogenic stroke and patent foramen ovale.

Authors:  Christian Tanislav; Manfred Kaps; Marek Jauss; Erwin Stolz; Wolfgang Pabst; Max Nedelmann; Mathias Grebe; Frank Reichenberger; Jens Allendoerfer
Journal:  BMC Neurol       Date:  2010-12-29       Impact factor: 2.474

9.  Factors associated with shunt dynamic in patients with cryptogenic stroke and patent foramen ovale: an observational cohort study.

Authors:  Christian Tanislav; Maximilian Puille; Mathias Grebe; Nicole Sieweke; Jens Allendörfer; Wolfgang Pabst; Manfred Kaps; Frank Reichenberger
Journal:  BMC Cardiovasc Disord       Date:  2011-08-26       Impact factor: 2.298

10.  Short-Term and Two-Year Rate of Recurrent Cerebrovascular Events in Patients with Acute Cerebral Ischemia of Undetermined Aetiology, with and without a Patent Foramen Ovale.

Authors:  Silvia Di Legge; Fabrizio Sallustio; Emiliano De Marchis; Costanza Rossi; Giacomo Koch; Marina Diomedi; Mauro Borzi; Francesco Romeo; Paolo Stanzione
Journal:  ISRN Neurol       Date:  2011-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.